Catriona Harvey

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

Xue Bai, Jiani Hu, Allison Betof Warner et al. · Clinical Cancer Research · 2021 · 176 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study

Xue Bai, Alexander N. Shoushtari, Allison Betof Warner et al. · British Journal of Dermatology · 2022 · 56 citations

Medicine, Dermatology, Oncology +17

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Leonie Müller‐Jensen, Sarah Zierold, Judith M. Versluis et al. · European Journal of Cancer · 2022 · 38 citations · Full text

Medicine, Neurology, Oncology +17

Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma—RIOMeso

Nicholas McNamee, Catriona Harvey, Lauren Gray et al. · Journal of Thoracic Oncology · 2023 · 33 citations · Full text

Medicine, Immunology, Oncology +14

Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series

Catriona Harvey, Kazi Nahar, Janet McKeown et al. · Journal for ImmunoTherapy of Cancer · 2024 · 11 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17